• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    DNAnexus Adds Jeff Margolis to Board of Directors

    10/21/22 8:05:00 AM ET
    $ALHC
    $BX
    $NXGN
    Medical Specialities
    Health Care
    Investment Managers
    Finance
    Get the next $ALHC alert in real time by email

    Industry veteran brings longstanding track record of growing innovative healthcare technology and service organizations from early-stage startup through category leadership

    DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the appointment of Jeff Margolis, a seasoned healthcare information technology executive and current Senior Advisor for Blackstone (NYSE:BX), to its Board of Directors. The appointment follows the company's $200 million financing round, which was led by Blackstone.

    "DNAnexus is already an exciting company at the intersection of healthcare and life sciences and the recent Blackstone investment will support the goal of becoming a category leader. The company's cloud-based platform is driving the world's largest biomedical research projects and enabling scientists to translate complex clinical, multi-omic, and phenotypic data into tangible insights for research and personalized medicine," said Mr. Margolis. "I'm looking forward to working with the talented management team and helping them empower customers with the tools to apply very large multi-omic data analytics to drive the next wave in digital transformation."

    "We're thrilled to welcome Jeff to our Board of Directors. He is a passionate leader with a proven track record of commercializing innovative healthcare technologies that solve urgent and complex healthcare challenges," said Richard Daly, CEO at DNAnexus. "His advice and perspective will be invaluable as we look to drive the global adoption of our leading platform and position the company for long-term success."

    Mr. Margolis' extensive industry experience includes 20 years as the CEO and/or chairman and another decade as a chief information and technology officer at publicly traded and private healthcare technology companies. He most recently served as the Chairman and CEO at Welltok, Inc., where he led the company from a pre-revenue startup to a leading enterprise consumer activation company. Before joining Welltok, Inc., Mr. Margolis founded and spent 14 years as CEO and Chairman of TriZetto Corporation, the first vertical SaaS enterprise software company.

    Mr. Margolis currently serves as Chairman at NextGen Healthcare (NASDAQ:NXGN), Vice Chairman at TriNetX, and as a board member at Alignment Healthcare (NASDAQ:ALHC), Hydrogen Health, and Grin. He serves as Chairman for the Hoag Clinic and the University of California at Irvine's Center for Digital Transformation. Mr. Margolis is a leadership fellow with the National Association of Corporate Directors and a member of the American Institute of Certified Public Accountants with a Certified Global Management Accountant designation. He holds a bachelor of science degree with high honors in business administration–management information systems from the University of Illinois at Urbana-Champaign.

    About DNAnexus

    DNAnexus is a leading provider of secure, scalable, and intuitive biomedical data analysis software and bioinformatics applications for the life sciences and healthcare communities. The company actively manages and supports more than 65 petabytes of complex genomic, multi-omic, and clinical datasets on behalf of a growing network of collaborations with large-scale biobanks, as well as leading pharmaceutical, clinical diagnostic, academic research, and government organizations. Scientists across 48 countries are now using the highly collaborative, cloud-based, end-to-end platform to gain data-driven insights that can advance scientific discovery, accelerate precision medicine, and improve patient care. For more information on DNAnexus, please visit www.dnanexus.com or follow the company @DNAnexus.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221021005048/en/

    Get the next $ALHC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC
    $BX
    $NXGN

    CompanyDatePrice TargetRatingAnalyst
    Alignment Healthcare Inc.
    $ALHC
    8/25/2025$21.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Alignment Healthcare Inc.
    $ALHC
    7/31/2025$13.00Underweight → Equal Weight
    Barclays
    Blackstone Inc.
    $BX
    4/8/2025$165.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Blackstone Inc.
    $BX
    3/17/2025$180.00Neutral → Buy
    UBS
    Blackstone Inc.
    $BX
    12/12/2024$188.00 → $195.00Overweight → Equal Weight
    Wells Fargo
    Blackstone Inc.
    $BX
    12/9/2024$149.00 → $230.00Hold → Buy
    TD Cowen
    Alignment Healthcare Inc.
    $ALHC
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    Alignment Healthcare Inc.
    $ALHC
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $ALHC
    $BX
    $NXGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Baratta Joseph sold $19,853,483 worth of shares (113,000 units at $175.69), decreasing direct ownership by 14% to 695,757 units (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Issuer)

    9/26/25 5:22:38 PM ET
    $BX
    Investment Managers
    Finance

    Large owner Blackstone Private Multi-Asset Credit & Income Fund bought $65,000,000 worth of Common Shares of Beneficial Interest (2,538,071 units at $25.61) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    9/22/25 5:56:51 PM ET
    $BX
    Investment Managers
    Finance

    Director General Atlantic (Aln Hlth), L.P. sold $99,999,997 worth of shares (6,246,096 units at $16.01) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    9/19/25 5:01:36 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $BX
    $NXGN
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Alignment Healthcare Inc.

    SCHEDULE 13G - Alignment Healthcare, Inc. (0001832466) (Subject)

    9/24/25 4:30:29 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Blackstone Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Blackstone Inc. (0001393818) (Filer)

    9/24/25 4:25:18 PM ET
    $BX
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    9/24/25 4:07:13 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $BX
    $NXGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Blackstone Private Multi-Asset Credit & Income Fund bought $65,000,000 worth of Common Shares of Beneficial Interest (2,538,071 units at $25.61) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    9/22/25 5:56:51 PM ET
    $BX
    Investment Managers
    Finance

    Large owner Blackstone Private Multi-Asset Credit & Income Fund bought $80,000,000 worth of Common Shares of Beneficial Interest (3,137,255 units at $25.50) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    8/22/25 4:15:16 PM ET
    $BX
    Investment Managers
    Finance

    Director Porat Ruth bought $46,699 worth of shares (274 units at $170.19), increasing direct ownership by 0.58% to 38,753 units (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Issuer)

    8/13/25 4:43:41 PM ET
    $BX
    Investment Managers
    Finance

    $ALHC
    $BX
    $NXGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health

    ORANGE, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Aging in place (64%), limited access to medical care (60%), and economic insecurity (51%) were cited by U.S. seniors as the top three barriers to their overall health, according to the 2025 Social Threats to Aging Well in America survey released by Alignment Health. The annual survey of more than 2,200 Americans ages 65 and older spotlights the social and environmental hurdles keeping older adults from living healthier, longer lives. Aging in place remains No.1 for the second consecutive year. This barrier impacts most seniors regardless of geography, income or education. More seniors are choosing to live independently and longer in their

    9/24/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Blackstone Credit & Insurance Leads $7 Billion Investment in Sempra Infrastructure Partners' Port Arthur LNG Phase 2

    Blackstone Credit & Insurance ("BXCI") is leading a $7 billion investment in Sempra Infrastructure Partners' Port Arthur LNG Phase 2. Funds managed by BXCI, together with an investor consortium, have acquired a 49.9% minority equity interest in the project. Sempra Infrastructure Partners has retained a 50.1% majority stake. "We are proud to partner with Sempra Infrastructure on this critical project which will help address rising global energy demands," said Rick Campbell, Senior Managing Director, Blackstone Credit & Insurance. "The partnership highlights Blackstone's focus on providing large scale and flexible high-grade capital solutions to the world's leading corporations." "This

    9/23/25 8:21:00 AM ET
    $BX
    Investment Managers
    Finance

    Blackstone Real Estate Announces Key Leadership Appointments

    Katie Keenan appointed CEO of BREIT and Global Head of Core+ Real Estate Tim Johnson appointed CEO of BXMT Blackstone (NYSE:BX) today announced several senior leadership updates within its Real Estate business. BREIT and Core+ Leadership Katie Keenan has been appointed Chief Executive Officer and a Director of Blackstone Real Estate Income Trust, Inc. ("BREIT") and Global Head of the Core+ Real Estate business. She succeeds Wesley M. LePatner, who served in both roles until her tragic passing on July 28, 2025. Ms. Keenan is a long-tenured Blackstone executive and has held numerous leadership positions since joining the firm in 2012. She currently serves as Global Co-Chief Investment

    9/19/25 8:40:00 AM ET
    $BX
    $BXMT
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $ALHC
    $BX
    $NXGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alignment Healthcare upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Alignment Healthcare from Sector Weight to Overweight and set a new price target of $21.00

    8/25/25 8:07:20 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by Barclays with a new price target

    Barclays upgraded Alignment Healthcare from Underweight to Equal Weight and set a new price target of $13.00

    7/31/25 8:54:42 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Blackstone upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Blackstone from Mkt Perform to Mkt Outperform and set a new price target of $165.00

    4/8/25 9:06:48 AM ET
    $BX
    Investment Managers
    Finance

    $ALHC
    $BX
    $NXGN
    Financials

    Live finance-specific insights

    View All

    $ALHC
    $BX
    $NXGN
    Leadership Updates

    Live Leadership Updates

    View All

    $ALHC
    $BX
    $NXGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics

    Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDARaises full-year outlook across same four metrics ORANGE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its second quarter ended June 30, 2025. "In today's Medicare Advantage environment, Alignment Healthcare's second quarter performance proves that strong financial results and high-quality care can go hand in hand – with the right model," said John Kao, found

    7/30/25 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025

    ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/45vdkr4b A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will re

    7/10/25 4:05:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

    Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDARaises midpoint of outlook ranges for 2025 year-end membership, revenue, adjusted gross profit and adjusted EBITDA, supported by strong first-quarter clinical performance and enrollment growth momentumAnnounces transition of Thomas Freeman from Chief Financial Officer (CFO) to Strategic Advisor to the CEO; names finance veteran Jim Head as CFO ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reporte

    5/1/25 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy

    ORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment's engagement and leadership in health care policy at federal and state levels, leading innovative business planning to anticipate changes in the health care environment to drive growth, and developing new initiatives and partnerships aligned with enterprise priorities. "With Alignment's growing influence and impact, Matt's appointment comes at exactly the ri

    9/8/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Blackstone Multi-Asset Investing (BXMA) Hires Monica Issar as Senior Managing Director

    Blackstone (NYSE:BX) today announced that Monica Issar will join Blackstone Multi-Asset Investing ("BXMA") as a Senior Managing Director based in New York where she will be the Head of Total Portfolio Management ("TPM"). Monica will join the TPM leadership team partnering closely with Co-Chief Investment Officers, Joe Dowling and David Ben-Ur. She will report directly to Joe Dowling, Global Head of Blackstone Multi-Asset Investing. "Monica is a proven leader with a remarkable track record of driving innovation in investment solutions and scaling multi-asset platforms," says Joe Dowling. "Her expertise will be pivotal in advancing BXMA's portfolio management capabilities and delivering val

    7/14/25 4:05:00 PM ET
    $BX
    Investment Managers
    Finance

    Blackstone Tactical Opportunities Hires Joseph Cassanelli as Senior Managing Director Focused on Financial Services Sector Investments

    Blackstone (NYSE:BX) announced today that Joseph Cassanelli, former Co-Head of Lazard's U.S. Financial Institutions Group, has joined Blackstone Tactical Opportunities ("Tac Opps") as a Senior Managing Director. Mr. Cassanelli will be based in New York and serve as an investment professional within Tac Opps focused on the financial services sector. Chris James, Global Head of Tac Opps, said: "Joe's deep expertise and relationships in the financial services sector make him an ideal addition to Tac Opps – as we continue to seek to deliver differentiated performance for our investors. We believe our scale and flexible capital are particularly well suited for today's market environment, and l

    6/16/25 10:30:00 AM ET
    $BX
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 1:28:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Blackstone Inc.

    SC 13G - Blackstone Inc. (0001393818) (Subject)

    11/13/24 3:07:30 PM ET
    $BX
    Investment Managers
    Finance